Immune surveillance via non-classical MHC class Ib molecules
通过非经典 MHC Ib 类分子进行免疫监视
基本信息
- 批准号:8503599
- 负责人:
- 金额:$ 18.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-07-03 至 2014-06-30
- 项目状态:已结题
- 来源:
- 关键词:AbbreviationsActivated Natural Killer CellAminopeptidaseAntigen Presentation PathwayAntigen ReceptorsAntigensAutoimmune DiseasesBone MarrowCD44 geneCD8B1 geneCell surfaceCellsChimera organismCodeComplexCytomegalovirusCytoplasmDefectDetectionDevelopmentDifferentiation AntigensEndoplasmic ReticulumFunctional disorderGene ExpressionGenesGoalsHistocompatibility Antigens Class IHumanIL2RB geneImmuneImmune TargetingImmune systemImmunologic SurveillanceIndividualLigandsMHC Class I GenesMolecular ProfilingMucous MembraneMusMutant Strains MiceMutateNatural Killer CellsPathway interactionsPatternPeptide/MHC ComplexPeptidesPopulationProteinsQa-1 AntigenReagentResearchSurveysT-Cell ReceptorT-Cell Receptors alpha-ChainT-LymphocyteT-Lymphocyte SubsetsTestingTranscriptUrsidae FamilyVariantVirusVirus DiseasesWild Type Mouseantigen processingbaseexperienceimprovedkiller T cellmouse modelneoplastic cellnovelpathogentumortumorigenic
项目摘要
DESCRIPTION (provided by applicant): The long term goal of our research is to understand and manipulate immune surveillance pathways. The MHC class I antigen processing pathway generates a vast repertoire of peptides as pMHC I ligands for the CD8 T cells. These pMHC I ligands inform the CD8 T cells of intracellular changes in the protein milieu caused by a virus infection or tumorigenic transformation. Not surprisingly, key steps of this pathway, such as the peptide transporter TAP, is frequently blocked by viruses and mutated in tumors. The immune system has also evolved counter strategies using NK cells to detect and eliminate cells with drastic changes in the pMHC repertoire due to defects in the antigen processing pathway. The ERAAP (or ERAP1), the ER aminopeptidase associated with antigen processing, is essential for generating the pMHC I repertoire. Recent studies with human autoimmune disorders, cytomegalovirus infected, and tumor cells have revealed that ERAAP expression is also altered in these conditions. However, the mechanism by which the immune system detects ERAAP dysfunction is not known. Here, we will test the hypothesis that a novel subpopulation of CD8 T cells, termed Qfl, with innate-like functions detects and eliminates cells with ERAAP deficiency. The Qfl CD8 T cells are specific for Qa-1b, non- classical MHC Ib molecule presenting the invariant FL9 peptide exclusively in ERAAP-deficient cells. The Qfl CD8 T cells can be detected, characterized and isolated using the Qa1/FL9 tetramer reagent. In well defined mouse models we will characterize the TCRs, function and developmental pathway of the Qfl subset of CD8 T cells to establish a potentially new paradigm for immune surveillance for defects in the antigen processing and presentation pathway.
描述(由申请人提供):我们研究的长期目标是了解和操纵免疫监视途径。MHC I类抗原加工途径产生大量肽作为CD 8 T细胞的pMHC I配体。这些pMHC I配体告知CD 8 T细胞由病毒感染或致瘤转化引起的蛋白质环境的细胞内变化。毫不奇怪,这一途径的关键步骤,如肽转运蛋白TAP,经常被病毒阻断,并在肿瘤中发生突变。免疫系统还发展了使用NK细胞来检测和消除由于抗原加工途径中的缺陷而在pMHC库中具有剧烈变化的细胞的对抗策略。 ERAAP(或ERAP 1),与抗原加工相关的ER氨肽酶,是产生pMHC I库所必需的。最近对人类自身免疫性疾病、巨细胞病毒感染和肿瘤细胞的研究表明,ERAAP表达在这些条件下也发生了改变。然而,免疫系统检测ERAAP功能障碍的机制尚不清楚。 在这里,我们将测试一种新的CD 8 T细胞亚群(称为Qfl)的假设,该亚群具有先天样功能,可以检测并消除ERAAP缺陷的细胞。Qfl CD 8 T细胞对Qa-1b具有特异性,Qa-1b是非经典MHC Ib分子,仅在ERAAP缺陷细胞中呈现不变的FL 9肽。可以使用Qal/FL 9四聚体试剂检测、表征和分离Qfl CD 8 T细胞。在明确定义的小鼠模型中,我们将表征CD 8 T细胞的Qfl亚群的TCR、功能和发育途径,以建立针对抗原加工和呈递途径中的缺陷的免疫监视的潜在新范例。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nilabh Shastri其他文献
Nilabh Shastri的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nilabh Shastri', 18)}}的其他基金
Unconventional sources of peptides for antigen presentation
用于抗原呈递的非常规肽来源
- 批准号:
9237812 - 财政年份:2017
- 资助金额:
$ 18.04万 - 项目类别:
Immune surveillance of antigen processing pathway
抗原加工途径的免疫监视
- 批准号:
9287264 - 财政年份:2017
- 资助金额:
$ 18.04万 - 项目类别:
Immune surveillance via non-classical MHC class Ib molecules
通过非经典 MHC Ib 类分子进行免疫监视
- 批准号:
8358263 - 财政年份:2012
- 资助金额:
$ 18.04万 - 项目类别: